Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897418 | 0.90 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL8895813 | 0.90 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL8895934 | 0.90 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8895770 | 0.89 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8899651 | 0.89 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8894995 | 0.89 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL11121258 | 0.77 | MAPT (0.46) | THRBMEN1KMT2AFAAH | |
| SCHEMBL11120615 | 0.77 | MAPT (0.46) | THRBMEN1KMT2AFAAH | |
| Hydrochloric Acid SCHEMBL4476184 | 0.77 | L3MBTL1 (0.49) | ALDH1A1HPGDLMNACHRM2CYP2C19 | |
| Hydrochloric Acid SCHEMBL4460799 | 0.77 | L3MBTL1 (0.49) | ALDH1A1HPGDLMNACHRM2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220030860-A1 | THERAPEUTIC COMPOSITION AND RELATED METHODS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2022-02-03 | — | — | US | disclosed |
| EP-3833186-A1 | THERAPEUTIC COMPOSITION AND RELATED METHODS | 3M Innovative Properties Company (US) | 2021-06-16 | — | — | EP | disclosed |
| WO-2020031065-A1 | THERAPEUTIC COMPOSITION AND RELATED METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-02-13 | — | — | WO | disclosed |
| US-9565857-B2 | Antimicrobial solutions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-02-14 | — | — | US | disclosed |
| US-20130231302-A1 | ANTIMICROBIAL SOLUTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-09-05 | — | — | US | disclosed |
| US-8450294-B2 | Shampoo compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| WO-2012034032-A2 | ANTIMICROBIAL SOLUTIONS | THE BOARD OF REGENTS OF UNBIVERSITY OF TEXAS SYSTEM (US) | 2012-03-15 | — | — | WO | disclosed |
| US-20090318571-A1 | Hydrocolloids and Process Therefor | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-12-24 | — | — | US | disclosed |
| EP-1841402-B9 | PROCESS FOR PREPARING HYDROCOLLOIDS | LUBRIZOL ADVANCED MAT INC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090137438-A1 | Hydrocolloids and Process Therefor | LUBRIZOL ADVANCED MATERIALS, INC. | 2009-05-28 | — | — | US | disclosed |
| EP-1135100-A4 | ORAL CARE COMPOSITIONS COMPRISING COENZYME Q 10? | PHARMA INC Q (US) | 2002-07-17 | — | — | EP | disclosed |
| EP-0911022-B1 | Ultramild antibacterial cleaning composition for frequent use | UNILEVER NV (NL) | 2002-03-27 | — | — | EP | disclosed |
| EP-1135100-A1 | ORAL CARE COMPOSITIONS COMPRISING COENZYME Q 10? | Q-Pharma, Inc. (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6200550-B1 | Oral care compositions comprising coenzyme Q10 | Q-PHARMA, INC. | 2001-03-13 | — | — | US | disclosed |
| WO-2000033802-A1 | ORAL CARE COMPOSITIONS COMPRISING COENZYME Q¿10? | Q-PHARMA, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| EP-0987321-A2 | Ultramild antibacterial cleaning composition for frequent use | UNILEVER N.V. (NL) | 2000-03-22 | — | — | EP | disclosed |
| EP-0911022-A1 | Ultramild antibacterial cleaning composition for frequent use | UNILEVER N.V. (NL) | 1999-04-28 | — | — | EP | disclosed |
| EP-0616521-A1 | ORAL COMPOSITIONS FOR INHIBITING PLAQUE AND CALCULUS FORMATION | THE DOW CHEMICAL COMPANY (US) | 1994-09-28 | — | — | EP | disclosed |
| WO-1993011741-A1 | ORAL COMPOSITIONS FOR INHIBITING PLAQUE AND CALCULUS FORMATION | THE DOW CHEMICAL COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0372603-A2 | Antibacterial oral composition | Colgate-Palmolive Company (US) | 1990-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231302-A1 | ANTIMICROBIAL SOLUTIONS | UGCG, GANAB, GANC | KDM4E 1145/4885THRB 4551/4885TDP1 2631/4885 |
| US-20090137438-A1 | Hydrocolloids and Process Therefor | ALG1, GYPA, HSD17B7 | KDM4E 2931/4885THRB 3916/4885TDP1 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.